Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 7, 2007
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST)Gian Marco Leggio, Vincenzo Micale, Filippo Drago
Bio-Protocol|March 4, 2021
The Discrete Paired-trial Variable-delay T-maze Task to Assess Working Memory in MiceGian Marco Leggio, Sebastiano Alfio Torrisi, Francesco Papaleo
Pharmacology & Therapeutics|July 13, 2019
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreasClaudio Bucolo, Gian Marco Leggio, Filippo Drago, et al.
F1000Research|April 15, 2017
New drugs in psychiatry: focus on new pharmacological targetsFilippo Caraci, Gian Marco Leggio, Salvatore Salomone, et al.
Brain Research|October 3, 2006
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesiaVincenzo Micale, Gian Marco Leggio, Carmen Mazzola, et al.
Biochemical Pharmacology|April 10, 2012
Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic ratsClaudio Bucolo, Gian Marco Leggio, Filippo Drago, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 12, 2010
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changesAlessandra Tamburella, Vincenzo Micale, Gian Marco Leggio, et al.
Molecular Genetics & Genomic Medicine|April 30, 2022
Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophreniaChiara Fabbri, Gian Marco Leggio, Filippo Drago, et al.
Frontiers in Pharmacology|May 7, 2019
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic SystemSebastiano Alfio Torrisi, Gian Marco Leggio, Filippo Drago, et al.
European Journal of Pharmacology|August 3, 2007
Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?Daniele Consoli, Gian Marco Leggio, Carmen Mazzola, et al.
Pageof 9